AI assistant
Predictive Oncology Inc. — Director's Dealing 2013
Aug 9, 2013
35106_dirs_2013-08-09_1649d67f-76aa-446b-9a63-6f4362dc89bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2013-08-06
Reporting Person: SOK Partners LLC (10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-08-06 | Convertible Promissory Note | $ | J | 0 | Acquired | Common Stock, par value $0.01 per share (37646714) | Direct |
Footnotes
F1: On August 6, 2013, SOK Partners LLC ("SOK Partners") advanced an additional $100,000 to the Issuer under the Convertible Promissory Note, dated March 28, 2012, made by the Issuer in favor of SOK Partners (the "Grid Note"). The Grid Note may be converted at any time by the holder into shares of the Issuer's common stock, par value $0.01 per share ("Shares"). The August 6, 2013 advance is convertible into 7,142,857 Shares.
F2: The aggregate principal amount and accrued interest of $527,054 as of August 6, 2013 under the Grid Note is convertible into an aggregate of 37,646,714 Shares.